Kopańko, M.; Zabłudowska, M.; Pawlak, D.; Sieklucka, B.; Krupa, A.; Sokołowska, K.; Ziemińska, M.; Pawlak, K.
The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. J. Clin. Med. 2024, 13, 1847.
https://doi.org/10.3390/jcm13071847
AMA Style
Kopańko M, Zabłudowska M, Pawlak D, Sieklucka B, Krupa A, Sokołowska K, Ziemińska M, Pawlak K.
The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. Journal of Clinical Medicine. 2024; 13(7):1847.
https://doi.org/10.3390/jcm13071847
Chicago/Turabian Style
Kopańko, Magdalena, Magdalena Zabłudowska, Dariusz Pawlak, Beata Sieklucka, Anna Krupa, Katarzyna Sokołowska, Marta Ziemińska, and Krystyna Pawlak.
2024. "The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment" Journal of Clinical Medicine 13, no. 7: 1847.
https://doi.org/10.3390/jcm13071847
APA Style
Kopańko, M., Zabłudowska, M., Pawlak, D., Sieklucka, B., Krupa, A., Sokołowska, K., Ziemińska, M., & Pawlak, K.
(2024). The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. Journal of Clinical Medicine, 13(7), 1847.
https://doi.org/10.3390/jcm13071847
